This report was first published by Endpoints News. To see the original version, click here
The FDA warned California-based ImmunityBio for a TV advertisement and podcast that gave the “misleading impression” that Anktiva, the company’s treatment for a type of bladder cancer, can cure or prevent all cancers.
The ad and podcast featured billionaire entrepreneur and ImmunityBio founder Patrick Soon-Shiong. He falsely claimed that Anktiva is “intended for new uses for which it lacks approval,” the FDA said in the warning letter released on Tuesday.
您已阅读25%（548字），剩余75%（1653字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。